SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-22-108100
Filing Date
2022-10-12
Accepted
2022-10-12 16:31:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM F-1 tm2227759d1_f1.htm F-1 561765
2 EXHIBIT 5.1 tm2227759d1_ex5-1.htm EX-5.1 36415
3 EXHIBIT 10.11 tm2227759d1_ex10-11.htm EX-10.11 242402
4 EXHIBIT 10.12 tm2227759d1_ex10-12.htm EX-10.12 208731
5 EXHIBIT 10.13 tm2227759d1_ex10-13.htm EX-10.13 32188
6 EXHIBIT 23.1 tm2227759d1_ex23-1.htm EX-23.1 3825
7 EXHIBIT 107 tm2227759d1_ex107.htm EX-FILING FEES 12611
8 GRAPHIC image_001.jpg GRAPHIC 3365
9 GRAPHIC image_003.jpg GRAPHIC 3257
  Complete submission text file 0001104659-22-108100.txt   1108499
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-267840 | Film No.: 221307145
SIC: 2834 Pharmaceutical Preparations